Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [978]

Problems with survivorship care in Europe

Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy

Problems with survivorship care in Europe ( Prof Francesco De Lorenzo - University of Naples Federico II, Naples, Italy )

Underprovision and inequality of specialised cancer care

Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece

Underprovision and inequality of specialised cancer care ( Dr Emmanouil Saloustros - General Hospital of Heraklion 'Venizelio', Crete, Greece )

PACIFIC trial of durvalumab for stage III NSCLC

Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain

PACIFIC trial of durvalumab for stage III NSCLC ( Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain )

Questioning the role of CT-scan in NSCLC post-surgery follow-up

Prof Virginie Westeel - University of Franche-Comté, Besançon, France

Questioning the role of CT-scan in NSCLC post-surgery follow-up ( Prof Virginie Westeel - University of Franche-Comté, Besançon, France )

Osimertinib suitable for first line EGFRm lung cancer

Dr Suresh Ramalingam - Winship Cancer Institute, Atlanta, USA

Osimertinib suitable for first line EGFRm lung cancer ( Dr Suresh Ramalingam - Winship Cancer Institute, Atlanta, USA )

FLAURA study of osimertinib versus TKI for 1st line NSCLC

Dr Suresh Ramalingam - Winship Cancer Institute, Druid Hills, USA

FLAURA study of osimertinib versus TKI for 1st line NSCLC ( Dr Suresh Ramalingam - Winship Cancer Institute, Druid Hills, USA )

Follow-up on the IFCT-0302 trial

Prof Virginie Westeel - University of Franche-Comté, Besançon, France

Follow-up on the IFCT-0302 trial ( Prof Virginie Westeel - University of Franche-Comté, Besançon, France )

PACIFIC trial of durvalumab for lung cancer

Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain

PACIFIC trial of durvalumab for lung cancer ( Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain )

Editor's Choice for August 2017

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for August 2017 ( Prof Gordon McVie - Founding Editor, ecancer )

Editor's Choice for July 17

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for July 17 ( Prof Gordon McVie - Founding Editor, ecancer )

iManageCancer: Serious Games for Kids

Stefan Hoffman - Serious Games Solutions, Potsdam, Germany

iManageCancer: Serious Games for Kids ( Stefan Hoffman - Serious Games Solutions, Potsdam, Germany )

Emerging targets for the treatment of lung cancer

Prof Tarek Mekhail - Florida Hospital Cancer Institute, Orlando, USA

Emerging targets for the treatment of lung cancer ( Prof Tarek Mekhail - Florida Hospital Cancer Institute, Orlando, USA )

More from ecancer